药物研究情况

资源中心

Resource

您现在的位置:

重磅消息 | FDA授予美国Fulcrum公司FSHD药物Losmapimod孤儿药称号


2020129Fulcrum TherapeuticsInc.FULCFDAlosmapimodODDlosmapimodp38α/βMAPKFSHDFulcrum使p38FSHD














FulcrumCEORobert J. Gould


FulcrumRobert J. GouldFSHDlosmapimod losmapimodFSHD20202b 使p38FSHD


201910losmapimodFSHD1losmapimodlosmapimod3,500


10342786使losmapimodFSHD2038



FDA200,000FDA7FDA


Losmapimod


Losmapimodp38α/βMAPKFulcrump38α/βDUX4广Fulcrum TherapeuticsFulcrump38α/βFSHDDUX4losmapimod3500losmapimod23losmapimod Fulcrum2losmapimodFSHD


Fulcrum


Fulcrum Therapeutics FulcrumLosmapimodFSHDFTX-6058β


FDAFulcrumFSHDLosmapimodFSHDFDAFDAFDAOrphan Drug ActFDA绿Losmapimod20208

Losmapimod20{12}{2}{2}{2}西{2}


文章原文请查看我们微信公众号:ChinaFSHD



https://mp.weixin.qq.com/s?__biz=MzI0MDU0OTE4NA==&mid=2247485489&idx=1&sn=db7ab8dbea2dd6030840f6435e772b05&chksm=e918641ede6fed08edc33e8295256fb9ce0d117a1e910182bb666d4f7d32ac2b9857b4e877f0&token=1833518193&lang=zh_CN#rd